About Converge Biotech
Converge Biotech is a Chemicals & Materials company based in Hyderabad (India) founded in 2014. Branded pharmaceutical formulations for chronic care are manufactured and distributed. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. The company has 183 employees. Its Indian entity Converge Biotech Private Limited reported revenue of ₹60.73 Cr. Converge Biotech offers products and services including Branded Formulations and Enzewhey 98. Its focus areas include Healthcare, Pharmaceuticals and Generic and Branded Formulations.
Company details
Converge Biotech, based in Hyderabad, India, is focused on the development and distribution of branded pharmaceutical formulations, particularly in the chronic care sector. The company is recognized for making high-quality and affordable medicines accessible to patients globally. Operations are extended into the Indian and international markets, with plans for further overseas expansion. Trust and long-term relationships are built with stakeholders, healthcare providers, and institutions in the global generic market.
- Headquarters Hyderabad, India
- Employees 183
- SectorsChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website convergebio.in
- Social LinkedIn X Facebook Instagram
- Legal Name Converge Biotech Pvt Ltd
- Date of Incorporation 26 Aug, 2014
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹60.73 Cr
FY 2024 · -6% YoY
- Net Profit₹2.53 Cr
FY 2024 · 4% margin
- EBITDA₹4.63 Cr
FY 2024 · 8% margin
- Latest Funding Round$897.91K (USD), Grant
Sep 2014
- Investors
- Employee Count183
Associated legal entities of Converge Biotech
Converge Biotech operates through Converge Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Converge Biotech Private Limited CIN U24233TG2014PTC095410 | Active | 26 Aug 2014 | Hyderabad, Telangana | ₹60.7 Cr | 183 | 4 | View details |
Products & Services of Converge Biotech
Converge Biotech offers a comprehensive portfolio of products and services, including Branded Formulations and Enzewhey 98.
Branded formulations are developed for chronic care sectors.
Enzewhey 98 is provided for critically ill patients.
Funding Insights of Converge Biotech
- Total Rounds 1
- Last Round Grant — $897,913
- First Round $897,913
(Sep 2014)
- Investors Count 1
All 1 funding rounds of Converge Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $897,913 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Converge Biotech
Converge Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Converge Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Converge Biotech Private Limited (Converge Biotech)
Converge Biotech Private Limited is the primary company behind Converge Biotech. The board of Converge Biotech Private Limited currently have 4 directors; the longest-serving is Bukka Srinivasu, appointed in 2014. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bukka Srinivasu DIN 03507273 | Director | 26 Aug 2014 | 12 yrs 2 mo | Converge Biotech Private Limited |
| Chandra Shekar Bukka DIN 03507270 | Director | 26 Aug 2014 | 12 yrs 2 mo | Converge Biotech Private Limited |
| Bijjala Arun Kumar DIN 06949784 | Managing Director | 26 Aug 2014 | 12 yrs 2 mo | Converge Biotech Private Limited |
| Bijjala Kavitha DIN 06935566 | Director | 26 Aug 2014 | 12 yrs 2 mo | Converge Biotech Private Limited |
People of Converge Biotech
20 people are tracked at Converge Biotech (5 in leadership, 15 in team); the tracked headcount is 183.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership | |
Arun Kumar Bijjalla | Founder, Managing Director | Leadership |
Divakar Singh | Assistant General Manager | Leadership |
Partha Roy Chowdhury | Chief Operating Officer | Leadership |
Keerthi Upendra | Regional Head | Leadership |
Eshwar Teja | Product Executive | Team |
Sridhar Ramachandran | Business Manager | Team |
Dr. Nirmala M | Product Executive | Team |
Saloni Bhatt | HR Manager | Team |
Ganesh Mokase | Territory Sales Manager | Team |
Praveen P | Regional Sales Manager | Team |
Chironton Dutta | Senior Regional Manager | Team |
Pocham Venkanna | Regonal Busines Manager | Team |
Dr K Indraja | Senior Product Executive | Team |
Pankaj Kumar | Territory Business Manager | Team |
Rahulkumar A | Administration Manager | Team |
Reetesh Verma | Regional Manager | Team |
Aditya Sharma | Area Business Manager | Team |
Palash Kavediya | CFA / Super Stockist | Team |
Kiran Proddutoori | Manager - Business Development & Digital Marketing | Team |
Complete people profiles for Converge Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Converge Biotech
Figures of Converge Biotech Private Limited, the primary company behind Converge Biotech, for FY 2024. Revenue was ₹60.73 Cr (-6% year on year). Net profit was ₹2.53 Cr (4% margin). EBITDA was ₹4.63 Cr (8% margin). Revenue has grown at a compounded annual rate of +21% over three years and +33% over five years.
- ₹60.73 CrRevenue · FY 2024 · -6% YoY
- ₹2.53 CrNet profit · 4% margin
- ₹4.63 CrEBITDA · 8% margin
- ₹50 LakhPaid-up capital
- 183Employees (provident fund records)
- +21%Revenue CAGR, 3 years
- +33%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Converge Biotech Private Limited are on its company page.
Detailed financial statements for Converge Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Converge Biotech
2 dated milestones of Converge Biotech, from founding to its latest funding, stage changes and deals.
- Founded Converge Biotech is founded.
- Funding First funding round of $898K.
Web traffic of Converge Biotech
The website of Converge Biotech (convergebio.in) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 55.6% vs previous month
Top companies in Core & Diversified Chemicals
3 companies that operate in the same segment as Converge Biotech (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate | 1979 | Pune, Maharashtra, India | USD 1.21 B | 1,020 | ||
Specialty chemicals are manufactured through integrated R&D and production processes. | 2023 | Bengaluru, Karnataka, India | USD 72.97 M | USD 2.13 M | ||
Manufactures coal tar and basic industrial chemicals. | 1987 | Kolkata, West Bengal, India | USD 24 M | USD 496.46 M | 2,480 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Converge Biotech
Complete news archive for Converge Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Converge Biotech
Converge Biotech was founded in 2014.
Converge Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Converge Biotech has 183 employees.
The primary company behind Converge Biotech, Converge Biotech Private Limited, reported revenue of ₹60.73 Cr for FY 2024, down 6% year on year.
Converge Biotech, based in Hyderabad, India, is focused on the development and distribution of branded pharmaceutical formulations, particularly in the chronic care sector. The company is recognized for making high-quality and affordable medicines accessible to patients globally. Operations are extended into the Indian and international markets, with plans for further overseas expansion. Trust and long-term relationships are built with stakeholders, healthcare providers, and institutions in the global generic market.
Converge Biotech offers Branded Formulations and Enzewhey 98.
Converge Biotech has 1 investor. Key investors include HHS.
Converge Biotech operates through Converge Biotech Private Limited.
The legal entities of Converge Biotech currently have 4 directors, including Bukka Srinivasu, Chandra Shekar Bukka, Bijjala Arun Kumar and others.